189 related articles for article (PubMed ID: 37737237)
1. Telomerase RNA-based aptamers restore defective myelopoiesis in congenital neutropenic syndromes.
Martínez-Balsalobre E; García-Castillo J; García-Moreno D; Naranjo-Sánchez E; Fernández-Lajarín M; Blasco MA; Alcaraz-Pérez F; Mulero V; Cayuela ML
Nat Commun; 2023 Sep; 14(1):5912. PubMed ID: 37737237
[TBL] [Abstract][Full Text] [Related]
2. Telomerase RNA recruits RNA polymerase II to target gene promoters to enhance myelopoiesis.
García-Castillo J; Alcaraz-Pérez F; Martínez-Balsalobre E; García-Moreno D; Rossmann MP; Fernández-Lajarín M; Bernabé-García M; Pérez-Oliva AB; Rodríguez-Cortez VC; Bueno C; Adatto I; Agarwal S; Menéndez P; Zon LI; Mulero V; Cayuela ML
Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34353901
[TBL] [Abstract][Full Text] [Related]
3. Posttranscriptional modulation of TERC by PAPD5 inhibition rescues hematopoietic development in dyskeratosis congenita.
Fok WC; Shukla S; Vessoni AT; Brenner KA; Parker R; Sturgeon CM; Batista LFZ
Blood; 2019 Mar; 133(12):1308-1312. PubMed ID: 30728146
[TBL] [Abstract][Full Text] [Related]
4. A non-canonical function of telomerase RNA in the regulation of developmental myelopoiesis in zebrafish.
Alcaraz-Pérez F; García-Castillo J; García-Moreno D; López-Muñoz A; Anchelin M; Angosto D; Zon LI; Mulero V; Cayuela ML
Nat Commun; 2014; 5():3228. PubMed ID: 24496182
[TBL] [Abstract][Full Text] [Related]
5. Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.
Gourronc FA; Robertson mM; Herrig AK; Lansdorp PM; Goldman FD; Klingelhutz AJ
Exp Dermatol; 2010 Mar; 19(3):279-88. PubMed ID: 19558498
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.
Yamaguchi H; Baerlocher GM; Lansdorp PM; Chanock SJ; Nunez O; Sloand E; Young NS
Blood; 2003 Aug; 102(3):916-8. PubMed ID: 12676774
[TBL] [Abstract][Full Text] [Related]
7. Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita.
Shukla S; Jeong HC; Sturgeon CM; Parker R; Batista LFZ
Blood Adv; 2020 Jun; 4(12):2717-2722. PubMed ID: 32559291
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
Marrone A; Sokhal P; Walne A; Beswick R; Kirwan M; Killick S; Williams M; Marsh J; Vulliamy T; Dokal I
Haematologica; 2007 Aug; 92(8):1013-20. PubMed ID: 17640862
[TBL] [Abstract][Full Text] [Related]
9. Dyskeratosis congenita: telomerase, telomeres and anticipation.
Marrone A; Walne A; Dokal I
Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
[TBL] [Abstract][Full Text] [Related]
10. HuR regulates telomerase activity through TERC methylation.
Tang H; Wang H; Cheng X; Fan X; Yang F; Zhang M; Chen Y; Tian Y; Liu C; Shao D; Jiang B; Dou Y; Cong Y; Xing J; Zhang X; Yi X; Songyang Z; Ma W; Zhao Y; Wang X; Ma J; Gorospe M; Ju Z; Wang W
Nat Commun; 2018 Jun; 9(1):2213. PubMed ID: 29880812
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.
Vulliamy T; Beswick R; Kirwan M; Marrone A; Digweed M; Walne A; Dokal I
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8073-8. PubMed ID: 18523010
[TBL] [Abstract][Full Text] [Related]
12. Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients.
Kirwan M; Beswick R; Vulliamy T; Nathwani AC; Walne AJ; Casimir C; Dokal I
Br J Haematol; 2009 Mar; 144(5):771-81. PubMed ID: 19036115
[TBL] [Abstract][Full Text] [Related]
13. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Marrone A; Dokal I
Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
[TBL] [Abstract][Full Text] [Related]
14. The effect of TERC haploinsufficiency on the inheritance of telomere length.
Goldman F; Bouarich R; Kulkarni S; Freeman S; Du HY; Harrington L; Mason PJ; Londoño-Vallejo A; Bessler M
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17119-24. PubMed ID: 16284252
[TBL] [Abstract][Full Text] [Related]
15. Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.
Pereboeva L; Hubbard M; Goldman FD; Westin ER
PLoS One; 2016; 11(2):e0148793. PubMed ID: 26859482
[TBL] [Abstract][Full Text] [Related]
16. TERT and TERC mutations detected in cryptic dyskeratosis congenita suppress telomerase activity.
Terada K; Miyake K; Yamaguchi H; Miyake N; Yamanaka K; Kojima S; Ito E; Inokuchi K; Okada T
Int J Lab Hematol; 2020 Jun; 42(3):316-321. PubMed ID: 32150348
[TBL] [Abstract][Full Text] [Related]
17. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients.
Agarwal S; Loh YH; McLoughlin EM; Huang J; Park IH; Miller JD; Huo H; Okuka M; Dos Reis RM; Loewer S; Ng HH; Keefe DL; Goldman FD; Klingelhutz AJ; Liu L; Daley GQ
Nature; 2010 Mar; 464(7286):292-6. PubMed ID: 20164838
[TBL] [Abstract][Full Text] [Related]
18. RNA polymerase II-binding aptamers in human ACRO1 satellites disrupt transcription
Boots JL; von Pelchrzim F; Weiss A; Zimmermann B; Friesacher T; Radtke M; Żywicki M; Chen D; Matylla-Kulińska K; Zagrovic B; Schroeder R
Transcription; 2020 Oct; 11(5):217-229. PubMed ID: 32663063
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency.
Marrone A; Stevens D; Vulliamy T; Dokal I; Mason PJ
Blood; 2004 Dec; 104(13):3936-42. PubMed ID: 15319288
[TBL] [Abstract][Full Text] [Related]
20. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
